Table 3.
Model 1 | Model 2 | Model 2 | Model 3 | Model 3 | Model 4 | Model 4 | |
---|---|---|---|---|---|---|---|
(full) | (trimmed) | (full) | (trimmed) | (full) | (trimmed) | ||
Within-person fixed effects | |||||||
Intercept | 2.17*** | 1.90*** | 2.21*** | 1.83*** | 2.25*** | 1.89*** | 2.25*** |
ADS (today), β01 | 0.05 | 0.06 | 0.07 | 0.06 | |||
Care subjective stress, β01 | 0.01*** | 0.01*** | 0.01** | 0.01*** | |||
Noncare subjective stress, β02 | 0.02 | 0.02 | 0.04*** | 0.04*** | |||
Positive effecta | −0.05 | −0.35*** | −0.35*** | ||||
Negative effect, β05 | 0.07 | ||||||
ADS × Care subjective stress, β04 | 0.00 | ||||||
ADS × Noncare subjective stress, β05 | 0.04* | 0.04* | |||||
Positive affect × Care subjective stress, β06 | 0.01 | ||||||
Positive affect × Noncare subjective stress, β07 | 0.00 | ||||||
Negative affect × Care subjective stress, β08 | 0.01 | ||||||
Negative affect × Noncare subjective stress, β09 | −0.04 | ||||||
ADS (yesterday), β01 | −0.06 | −0.05 | |||||
ADS (yesterday)*Positive affect, β 03 | 0.33** | 0.33** | |||||
Between-person fixed effects | |||||||
Caregiver age, β10 | −0.01 | 0.00 | 0.00 | −0.01 | |||
Caregiver gender, β20 | −0.26 | −0.29 | −0.35 | −0.10 | |||
Duration of care, β30 | 0.00 | 0.00 | 0.00 | 0.00 | |||
IWD ADL impairment, β40 | 0.12 | 0.07 | 0.08 | 0.11 | |||
OTC medication use, β50 | 0.09 | 0.09 | 0.07 | 0.11 | |||
Caregiver pain frequency, β60 | 0.35*** | 0.29*** | 0.31*** | 0.30*** | 0.38*** | 0.34*** | 0.35*** |
Caregiver pain interference, β70 | 0.22** | 0.14** | 0.17** | 0.10 | 0.18** | 0.17 | |
Extent of ADS use, β80 | 0.03 | 0.09 | 0.09 | ||||
Care subjective stress, β90 | 0.01 | 0.01 | |||||
Noncare subjective stress, β100 | 0.08** | 0.10** | 0.05 | ||||
Positive affect, β110 | −0.11 | ||||||
Negative affect, β120 | 0.38 | ||||||
Random effects | |||||||
σ2 | 0.56*** | 0.53*** | 0.53*** | 0.53*** | 0.54*** | 0.50*** | 0.50*** |
τ00 | 0.72*** | 0.66*** | 0.68*** | 0.64*** | 0.77*** | 0.77*** | 0.78*** |
BIC | 3289.88 | 3114.39 | 3078.48 | 3130.69 | 3082.86 | 2683.88 | 2665.16 |
aPositive affect was estimated by β04 in Model 3 and β02 in Model 4.
**p < .01. ***p < .001.